Director William H. Rastetter sold Neurocrine Biosciences ($NBIX) shares on the open market twice in the last year, for a total of $6.04 million. His most recent sale occurred on November 5, 2025. These sales rank 1,677th among 11,678 individual insiders, below the average sale amount of $8.6 million across 6.4 transactions. Rastetter made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 5, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | RASTETTER WILLIAM H | Director | M | Common Stock | 18000 | $47.89 | 58,360.0000 | 102,500,000 | 44.60% | 0.02% |
| Nov. 5, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | RASTETTER WILLIAM H | Director | M | Non-Qualified Stock Option | 18000 | $0.00 | 0.0000 | 102,500,000 | 100.00% | 0.02% |
| Nov. 5, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | RASTETTER WILLIAM H | Director | S | Common Stock | 18000 | $151.82 | 40,360.0000 | 102,500,000 | 30.84% | 0.02% |
| July 9, 2025 | Dare Bioscience, Inc. | $DARE | RASTETTER WILLIAM H | Director | A | Stock Option (right to buy) | 4500 | $0.00 | 4,500.0000 | 9,030,386 | 9999.99% | 0.05% |
| May 29, 2025 | FATE THERAPEUTICS INC | $FATE | RASTETTER WILLIAM H | Not found | A | Stock Option (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 113,685,177 | 9999.99% | 0.05% |
| May 22, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | RASTETTER WILLIAM H | Director | M | Restricted Stock Unit | 2869 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.00% |
| May 22, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | RASTETTER WILLIAM H | Director | M | Common Stock | 2869 | $0.00 | 40,360.0000 | 103,700,000 | 7.65% | 0.00% |
| May 21, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | RASTETTER WILLIAM H | Director | A | Restricted Stock Unit | 3318 | $0.00 | 3,318.0000 | 103,700,000 | 9999.99% | 0.00% |
| May 5, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | RASTETTER WILLIAM H | Director | S | Common Stock | 30000 | $110.20 | 37,491.0000 | 103,700,000 | 44.45% | 0.03% |
| May 5, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | RASTETTER WILLIAM H | Director | M | Common Stock | 30000 | $42.76 | 67,491.0000 | 103,700,000 | 80.02% | 0.03% |
| May 5, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | RASTETTER WILLIAM H | Director | M | Non-Qualified Stock Option | 30000 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.03% |
| Aug. 15, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | RASTETTER WILLIAM H | Director | S | Common Stock | 14250 | $146.69 | 37,491.0000 | 101,000,000 | 27.54% | 0.01% |
| June 7, 2024 | FATE THERAPEUTICS INC | $FATE | RASTETTER WILLIAM H | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 98,411,162 | 9999.99% | 0.04% |
| June 5, 2024 | Dare Bioscience, Inc. | $DARE | RASTETTER WILLIAM H | Director | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 8,381,825 | 9999.99% | 0.48% |
| May 22, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | RASTETTER WILLIAM H | Director | A | Restricted Stock Unit | 2869 | $0.00 | 2,869.0000 | 101,000,000 | 9999.99% | 0.00% |
| Jan. 2, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | RASTETTER WILLIAM H | Director | M | Non-Qualified Stock Option | 20000 | $12.98 | 0.0000 | 101,000,000 | 100.00% | 0.02% |
| Jan. 2, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | RASTETTER WILLIAM H | Director | S | Common Stock | 11044 | $131.47 | 51,741.0000 | 101,000,000 | 17.59% | 0.01% |
| Jan. 2, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | RASTETTER WILLIAM H | Director | M | Common Stock | 20000 | $12.98 | 62,785.0000 | 101,000,000 | 46.75% | 0.02% |
| June 21, 2023 | Dare Bioscience, Inc. | $DARE | RASTETTER WILLIAM H | Director | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 7,068,790 | 9999.99% | 0.57% |
| June 6, 2023 | FATE THERAPEUTICS INC | $FATE | RASTETTER WILLIAM H | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| May 17, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | RASTETTER WILLIAM H | Director | A | Non-Qualified Stock Option | 8579 | $0.00 | 8,579.0000 | 98,900,000 | 9999.99% | 0.01% |
| May 1, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | RASTETTER WILLIAM H | Director | M | Non-Qualified Stock Option | 7625 | $12.71 | 0.0000 | 98,900,000 | 100.00% | 0.01% |
| May 1, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | RASTETTER WILLIAM H | Director | M | Common Stock | 7625 | $12.71 | 47,085.0000 | 98,900,000 | 19.32% | 0.01% |
| May 1, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | RASTETTER WILLIAM H | Director | S | Common Stock | 4300 | $101.43 | 42,785.0000 | 98,900,000 | 9.13% | 0.00% |
| April 21, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | RASTETTER WILLIAM H | Director | M | Common Stock | 10765 | $12.71 | 45,494.0000 | 98,900,000 | 31.00% | 0.01% |
| April 21, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | RASTETTER WILLIAM H | Director | S | Common Stock | 6034 | $105.04 | 39,460.0000 | 98,900,000 | 13.26% | 0.01% |
| April 19, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | RASTETTER WILLIAM H | Director | M | Non-Qualified Stock Option | 1610 | $12.71 | 18,390.0000 | 98,900,000 | 8.05% | 0.00% |
| April 21, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | RASTETTER WILLIAM H | Director | M | Non-Qualified Stock Option | 10765 | $12.71 | 7,625.0000 | 98,900,000 | 58.54% | 0.01% |
| April 19, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | RASTETTER WILLIAM H | Director | S | Common Stock | 903 | $105.00 | 34,729.0000 | 98,900,000 | 2.53% | 0.00% |
| April 19, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | RASTETTER WILLIAM H | Director | M | Common Stock | 1610 | $12.71 | 35,632.0000 | 98,900,000 | 4.73% | 0.00% |